Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report

Journal article

Peer reviewed

Masaki Otsuka, Osamu Yamasaki, Tatsuya Kaji, Tadahiko Shien, Keiji Iwatsuki and Shasa Hu

JAMA dermatology (Chicago, Ill.), Vol.152(1), pp.111-113

2016-01

PMID: 26375389

Abstract

Adenocarcinoma - drug therapy

Adenocarcinoma - pathology

Antibodies, Monoclonal, Humanized - administration & dosage

Antineoplastic Combined Chemotherapy Protocols - therapeutic use

Apocrine Glands - pathology

Follow-Up Studies

Humans

Male

Middle Aged

Molecular Targeted Therapy

Skin Neoplasms - drug therapy

Skin Neoplasms - pathology

Sweat Gland Neoplasms - drug therapy

Sweat Gland Neoplasms - pathology

Taxoids - administration & dosage

Treatment Outcome

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.158 Dermatology - General; 1.158.1583 Pilomatrixoma
Web Of Science research areas: Dermatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report
Creators: Masaki Otsuka - Shizuoka Cancer Center
Osamu Yamasaki - Okayama University
Tatsuya Kaji - Okayama University
Tadahiko Shien - Okayama University
Keiji Iwatsuki - Okayama University
Shasa Hu - UMMG Dept of Dermatology & Cutaneous Surgery
Publication Details: JAMA dermatology (Chicago, Ill.), Vol.152(1), pp.111-113
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
PMID: 26375389
Record Identifier: 991031723510002976